Fig. 1From: A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumorsBlood, plasma, and urine clearance for nano-carrier 188Re-liposome in patients. The radioactivity that is measured in whole blood samples is identical to that in the plasma after centrifugationBack to article page